Cargando…

Identification of PLA2G7 as a novel biomarker of diffuse large B cell lymphoma

BACKGROUND: Diffuse large B-cell lymphoma is the most common form of non-Hodgkin lymphoma globally, and patients with relapsed or refractory DLBCL typically experience poor long-term outcomes. METHODS: Differentially expressed genes associated with DLBCL were identified using two GEO datasets in an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Weili, Lin, Qiaochu, Issah, Mohammed Awal, Liao, Ziyuan, Shen, Jianzhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369790/ https://www.ncbi.nlm.nih.gov/pubmed/34404374 http://dx.doi.org/10.1186/s12885-021-08660-4

Ejemplares similares

A miR-129-5P/ARID3A Negative Feedback Loop Modulates Diffuse Large B Cell Lymphoma Progression and Immune Evasion Through Regulating the PD-1/PD-L1 Checkpoint
por: Zheng, Weili, et al.
Publicado: (2021)

CD56-positive diffuse large B-cell lymphoma/leukemia with BCL6/MYC double-hit and multiple gene mutations: an indicator of poor prognosis?
por: Liu, Yanquan, et al.
Publicado: (2020)

Epigenetic modifications in acute myeloid leukemia: The emerging role of circular RNAs (Review)
por: Issah, Mohammed Awal, et al.
Publicado: (2021)

Rapid identification of novel independent serum biomarkers in diffuse large B-cell lymphoma
por: Che, Yi-Qun, et al.
Publicado: (2020)

Impact of Qi-Invigorating Traditional Chinese Medicines on Diffuse Large B Cell Lymphoma Based on Network Pharmacology and Experimental Validation
por: Huang, Qian, et al.
Publicado: (2021)

Identification of microtubule-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
por: Wu, Wenqi, et al.
Publicado: (2023)

High pretreatment plasma D-dimer levels predict poor survival in patients with diffuse large B-cell lymphoma in the real world
por: Huang, Haobo, et al.
Publicado: (2021)

Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
por: Wu, Wenqi, et al.
Publicado: (2023)

PLA2G7, caloric restriction and cardiovascular aging
por: Cao, Fang, et al.
Publicado: (2022)

Deubiquitinase OTUD7B is a potential prognostic biomarker in diffuse large B-cell lymphoma
por: Qiu, Shi, et al.
Publicado: (2022)

Abnormal upregulation of cardiovascular disease biomarker PLA2G7 induced by proinflammatory macrophages in COVID-19 patients
por: Li, Yang, et al.
Publicado: (2021)

Molecular Heterogeneity in Localized Diffuse Large B-Cell Lymphoma
por: Qin, Wei, et al.
Publicado: (2021)

Matrix Metallopeptidase 14: A Candidate Prognostic Biomarker for Diffuse Large B-Cell Lymphoma
por: Yin, Chengliang, et al.
Publicado: (2020)

Serum Cystatin C as a Biomarker in Diffuse Large B-Cell Lymphoma
por: Hammouda, Nada E., et al.
Publicado: (2017)

Integrated Genomic and Transcriptomic Analyses of Diffuse Large B-Cell Lymphoma With Multiple Abnormal Immunologic Markers
por: Sheng, Lingshuang, et al.
Publicado: (2022)

Sequencing of Lp-PLA2-encoding PLA2G7 gene in 2000 Europeans reveals several rare loss-of-function mutations
por: Song, K, et al.
Publicado: (2012)

PLA2G7: a new player in shaping energy metabolism and lifespan
por: Candels, Lena Susanna, et al.
Publicado: (2022)

Prognostic values of geriatric nutritional risk index (GNRI) and prognostic nutritional index (PNI) in elderly patients with Diffuse Large B-Cell Lymphoma
por: Yan, Dongmei, et al.
Publicado: (2021)

CD7-Positive Diffuse Large B-Cell Lymphoma Presenting as an Intranasal Tumor
por: Teshima, Kazuaki, et al.
Publicado: (2020)

Circulating RNA biomarkers in diffuse large B-cell lymphoma: a systematic review
por: Decruyenaere, Philippe, et al.
Publicado: (2021)

Advances in Multi-Omics Study of Prognostic Biomarkers of Diffuse Large B-Cell Lymphoma
por: Liang, Xiao-jie, et al.
Publicado: (2022)

Clinicopathological analysis of diffuse large B-cell lymphoma using molecular biomarkers: a retrospective analysis from 7 Hungarian centers
por: Balikó, Anett, et al.
Publicado: (2023)

Novel PLA2G6 Pathogenic Variants in Chinese Patients With PLA2G6-Associated Neurodegeneration
por: Wan, Yalan, et al.
Publicado: (2022)

Novel bioinformatic classification system for genetic signatures identification in diffuse large B-cell lymphoma
por: Zhang, Wei, et al.
Publicado: (2020)

Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma
por: Kleo, Karsten, et al.
Publicado: (2019)

The Addition of Ferritin Enhanced the Prognostic Value of International Prognostic Index in Diffuse Large B‐Cell Lymphoma
por: Shen, Ziyuan, et al.
Publicado: (2022)

Unusual Cardiac Infiltration in Diffuse Large B-Cell Lymphoma
por: Moustafa, Sherif, et al.
Publicado: (2014)

PLA2G12A as a Novel Biomarker for Colorectal Cancer with Prognostic Relevance
por: Parisi, Eva, et al.
Publicado: (2023)

Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation
por: Hodkinson, Brendan P., et al.
Publicado: (2020)

Identification and Validation of a Prognostic Prediction Model in Diffuse Large B-Cell Lymphoma
por: Yan, Jiaqin, et al.
Publicado: (2022)

Identification of a prognostic metabolic gene signature in diffuse large B‐cell lymphoma
por: Wang, Huizhong, et al.
Publicado: (2021)

Identification and validation of 5-methylcytosine-associated genes in diffuse large B-cell lymphoma
por: Xing, Cheng, et al.
Publicado: (2023)

Identification of Inflammation-Related Biomarker Lp-PLA2 for Patients With COPD by Comprehensive Analysis
por: Deng, Mingming, et al.
Publicado: (2021)

Prognostic Biomarkers and EBV Infection Research in Diffuse Large B-Cell Lymphoma of the Palatine Tonsils
por: Marques, Marinho, et al.
Publicado: (2012)

Circulating miRNAs as biomarkers in diffuse large B-cell lymphoma: a systematic review
por: Lopez-Santillan, Maria, et al.
Publicado: (2018)

Biomarkers and novel therapeutic approaches for diffuse large B-cell lymphoma in the era of precision medicine
por: Lodhi, Niraj, et al.
Publicado: (2020)

The Prognostic Value of Blood-Based Biomarkers in Patients With Testicular Diffuse Large B-Cell Lymphoma
por: Yang, Jing, et al.
Publicado: (2019)

Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications
por: Papageorgiou, Sotirios G., et al.
Publicado: (2021)

RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma
por: Xu, Cong, et al.
Publicado: (2022)

The long non-coding RNA NONHSAG026900 predicts prognosis as a favorable biomarker in patients with diffuse large B-cell lymphoma
por: Zhao, Shuangtao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t70a15jmu7rohj3rgmmc0a2um1